Real World Data, a Fast-Track for Clinical Trials

Mounting evidence suggests that drug companies can benefit from alternative data sources, collected by patients themseles to improve the process of clinical trials namely:

  • To improve clinical trial recruitment
  • To keep patients engaged during and after trials
  • To fast-track drug approvals, monitoring outcomes post-market launch

To leverage the wealth of data brought about by the digital health revolution, pharma must invent new research partnerships with patients, securing their buy-in to collect precious data. This means:

  • Securing patient consent
  • Offering practical ways for patients to control their data
  • Rewarding patients to contribute more
Read more about  this changing paradigm

Download Document